LASER

LASER Assisted Staphylococcal ERadication prior to elective orthopaedic implantation surgery (LASER study): Pilot study Phase I

The LASER Study

In this study we want to find out how efficient the current treatment to eradicate S. aureus bacteria is in patients undergoing orthopaedic surgery. We also want to review the procedures that we will use in future trials where we will aim to increase the effectiveness of the current treatment.

 

Chief Investigator: Prof. T. Walsh

Number and location of participating sites (by region/ country): 1 site in Edinburgh

ISRCTN number: 28026496  http://www.isrctn.com/search?q=28026496

Funder: SELEX ES

Start and End date

Of grant award: 1 October 2015 -  20 October 2018 (LASER Pilot 1, LASER Pilot 2)

Of recruitment: 20 October 2015 - 12 September 2016 (LASER Pilot 1)

Of recruitment: (LASER Pilot 2)

 

Status: Pilot 1: in follow up

Status: Pilot 2: in set up 

 

GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with GDPR, please read this document.

                              

Contact details:   Co-sponsors - University of Edinburgh & NHS Lothian, ACCORD 

Chief Investigator: Prof T, Walsh, Professor of Critical Care, Edinburgh University, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4TJ.

Trial manager: Julia Boyd, Edinburgh Clinical Trials Unit, University of Edinburgh, University of Edinburgh, Nine Edinburgh Bioquarter, 9 Little France Road, EDINBURGH, EH16 4UX.  Julia.Boyd@ed.ac.uk

 

ECTU involvement: Trial management / Statistics / Database provision

(UKCRC)

This article was published on